Patent · US Active

Method of treating graft versus host disease using IL-2 muteins

US9732134B2 · kind B2 · utility

34Cited by
16References
3Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 8, 2012
Grant dateAug 15, 2017
Priority date—
Expiry dateNov 8, 2032

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K38/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Described herein are immunosuppressive molecules including immunosuppressive variants of IL-2, and use of such molecules to treat inflammatory and autoimmune disorders.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.